Hatch-Waxman Safe Harbor Murky After High Court Rejection
The U.S. Supreme Court decided Monday to not hear a case over the scope of the Hatch-Waxman Act safe harbor that protects allegedly infringing conduct involving pharmaceutical patents, leaving uncertain whether...To view the full article, register now.
Already a subscriber? Click here to view full article